Zeya Health, a Singapore-based healthtech startup specializing in AI-powered clinic operations, has secured $575,000 in pre-seed funding to expand its intelligent automation platform across Southeast Asia and India. The round, led by regional investors and supported by healthcare-focused angels, will fuel product development, regional hiring, and pilot deployments in multi-specialty and primary care clinics seeking to reduce administrative burden and improve patient flow.
Glimpse:
Announced on January 14, 2026, the funding will support Zeya’s core platform which automates appointment scheduling, patient intake, billing reconciliation, inventory tracking, and real-time reporting using conversational AI and workflow orchestration. Already live in more than 40 clinics across Singapore and Malaysia, Zeya aims to reach 200+ facilities by the end of 2026 while preparing for deeper penetration into India’s rapidly digitizing private healthcare market.
Zeya Health, the Singapore-headquartered startup building AI-native tools to modernize clinic operations, has closed a $575,000 pre-seed funding round to scale its automation platform across Southeast Asia and India. The round, completed in mid-January 2026, was led by a consortium of regional investors with strong healthcare and technology portfolios, alongside participation from prominent angel investors in the APAC digital health space.
The company’s flagship product is a unified AI orchestration layer that automates the majority of repetitive administrative tasks in outpatient clinics. Using natural language interfaces, predictive scheduling, and intelligent document processing, Zeya’s platform handles patient onboarding, appointment optimization, insurance verification, billing reconciliation, inventory alerts, and real-time performance dashboards all without requiring clinics to replace existing systems. Early deployments have demonstrated reductions in front-desk workload by up to 60% and improvements in appointment slot utilization by 20–30%, according to internal customer data.
Co-founder and CEO Anirudh Sridharan stated: “Clinics in Southeast Asia and India are under immense pressure to deliver more care with the same or fewer resources. Most automation tools today are rigid and expensive. Zeya is different we built a flexible, AI-first layer that works with whatever systems clinics already have, delivering immediate operational relief while preserving the human touch.”
The fresh capital will be used to accelerate product development, expand the engineering and go-to-market teams in Singapore, Malaysia, and India, and support pilot programs with mid-sized and large multi-specialty clinic chains. Zeya is particularly focused on India, where private healthcare is growing rapidly but remains fragmented and operationally strained.
The company already has live installations in more than 40 clinics across Singapore and Malaysia and expects to reach 200+ facilities by the end of 2026. Early feedback from clinic owners highlights the platform’s ease of adoption and measurable impact on both staff satisfaction and patient experience.
Zeya Health’s funding round comes at a pivotal time for APAC healthtech, where operational efficiency tools are gaining traction as clinics face rising patient volumes, staffing shortages, and margin pressure. By focusing on lightweight, AI-driven automation rather than full EMR replacements, Zeya is carving out a distinct and increasingly competitive position in the region’s evolving digital health landscape.
“Clinics don’t need another software suite they need intelligence that works invisibly to make their day smoother. That’s what Zeya delivers.”
By
HB Team
